{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:15:11Z","timestamp":1789784111143,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bcmd.2010.10.010","type":"journal-article","created":{"date-parts":[[2010,11,14]],"date-time":"2010-11-14T04:28:22Z","timestamp":1289708902000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Potential biomarkers of osteonecrosis in Gaucher disease"],"prefix":"10.1016","volume":"46","author":[{"given":"Elena V.","family":"Pavlova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick B.","family":"Deegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Tindall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralyn","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Edmond","family":"Wraith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcmd.2010.10.010_bb0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1399-0004.2007.00769.x","article-title":"The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease","volume":"71","author":"Charrow","year":"2007","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.bcmd.2010.10.010_bb0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.bcmd.2010.10.010_bb0015","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br. J. Radiol."},{"issue":"Suppl 2","key":"10.1016\/j.bcmd.2010.10.010_bb0020","first-page":"106","article-title":"Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses","volume":"24","author":"Cox","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.bcmd.2010.10.010_bb0025","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcmd.2010.10.010_bb0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.bcmd.2010.10.010_bb0035","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcmd.2010.10.010_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bcmd.2010.10.010_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bcmd.2005.05.005","article-title":"Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease","volume":"35","author":"Deegan","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.bcmd.2010.10.010_bb0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0925-4439(96)00056-7","article-title":"Plasma tumor necrosis factor-a (THF-a) levels in Gaucher disease","volume":"1317","author":"Michelakakis","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bcmd.2010.10.010_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/qjmed\/90.1.19","article-title":"Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased of interleukin-6 and interleukin-10","volume":"90","author":"Allen","year":"1997","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.bcmd.2010.10.010_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/bcmd.1997.0137","article-title":"Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease","volume":"23","author":"Hollak","year":"1997","journal-title":"Blood Cells Mol. Dis."},{"issue":"4","key":"10.1016\/j.bcmd.2010.10.010_bb0065","doi-asserted-by":"crossref","first-page":"R156","DOI":"10.1186\/ar3111","article-title":"Bone events and evolution of biologic markers in Gaucher disease before and during treatment","volume":"2","author":"Stirnemann","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"4 Suppl 5","key":"10.1016\/j.bcmd.2010.10.010_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Semin. Hematol."},{"issue":"4 Suppl 5","key":"10.1016\/j.bcmd.2010.10.010_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2004.07.010","article-title":"Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients","volume":"41","author":"Weinreb","year":"2004","journal-title":"Semin. Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2010.10.010_bb0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.GIM.0000153660.88672.3C","article-title":"Individualization of long-term enzyme replacement therapy for Gaucher disease","volume":"7","author":"Andersson","year":"2005","journal-title":"Genet. Med."},{"key":"10.1016\/j.bcmd.2010.10.010_bb0085","doi-asserted-by":"crossref","unstructured":"P.B. Deegan, E.V. Pavlova, J. Tindall, P. Stein, P. Bearcroft, A. Mehta, D. Hughes, et al. Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy. Medicine (Baltimore) 90 (1) (2011), in press.","DOI":"10.1097\/MD.0b013e3182057be4"},{"key":"10.1016\/j.bcmd.2010.10.010_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-1759(99)00069-1","article-title":"Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay","volume":"227","author":"Carson","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bcmd.2010.10.010_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/1097-0320(20010901)45:1<27::AID-CYTO1141>3.0.CO;2-I","article-title":"Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants","volume":"45","author":"Kellar","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.bcmd.2010.10.010_bb0100","series-title":"Calibration curve-fitting","first-page":"198","author":"Nix","year":"2001"},{"issue":"1","key":"10.1016\/j.bcmd.2010.10.010_bb0105","first-page":"133","article-title":"Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells","volume":"10","author":"de Jager","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.bcmd.2010.10.010_bb0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jim.2005.03.009","article-title":"Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies","volume":"300","author":"de Jager","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bcmd.2010.10.010_bb0115","doi-asserted-by":"crossref","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","article-title":"The human chitotriosidase gene. Nature of inherited enzyme deficiency","volume":"273","author":"Boot","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2010.10.010_bb0120","first-page":"977","article-title":"Chitotriosidase genotype and plasma activity in patients type 1 Gaucher's disease and their relatives (carriers and non carriers)","volume":"86","author":"Giraldo","year":"2001","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bcmd.2010.10.010_bb0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2007.02.042","article-title":"Monitoring of Gaucher patients with a novel chitotriosidase assay","volume":"381","author":"Schoonhoven","year":"2007","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.bcmd.2010.10.010_bb0130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.bcmd.2010.10.010_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bcmd.2010.10.010_bb0140","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4049\/jimmunol.159.3.1140","article-title":"A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha\/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes","volume":"159","author":"Hieshima","year":"1997","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bcmd.2010.10.010_bb0145","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","article-title":"Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease","volume":"1772","author":"van Breemen","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bcmd.2010.10.010_bb0150","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.4049\/jimmunol.160.3.1411","article-title":"Alternative macrophage activation associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern","volume":"160","author":"Kodelja","year":"1998","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bcmd.2010.10.010_bb0155","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bcmd.1997.0156","article-title":"Cytokine mRNA in Gaucher disease","volume":"23","author":"Lichtenstein","year":"1997","journal-title":"Blood Cells Mol. Dis."},{"issue":"15","key":"10.1016\/j.bcmd.2010.10.010_bb0160","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood-2009-02-205708","article-title":"Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome","volume":"114","author":"Campeau","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.10.010_bb0165","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1073\/pnas.84.24.9233","article-title":"Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines","volume":"84","author":"Yoshimura","year":"1987","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bcmd.2010.10.010_bb0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00208938","article-title":"Monocyte-derived neutrophil chemotactic factor (MDNCF\/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily","volume":"84","author":"Modi","year":"1990","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.bcmd.2010.10.010_bb0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jlb.59.1.39","article-title":"Some aspects of IL-8 pathophysiology. III: Chemokine interaction with endothelial cells","volume":"59","author":"Rot","year":"1996","journal-title":"J. Leukoc. Biol."},{"issue":"5089","key":"10.1016\/j.bcmd.2010.10.010_bb0180","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.1281554","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis","volume":"11","author":"Koch","year":"1992","journal-title":"Science"},{"issue":"2\u20133","key":"10.1016\/j.bcmd.2010.10.010_bb0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1385\/IR:21:2-3:129","article-title":"Interleukin-8 and its receptor CXCR2 in atherosclerosis","volume":"21","author":"Boisvert","year":"2000","journal-title":"Immunol. Res."},{"issue":"3","key":"10.1016\/j.bcmd.2010.10.010_bb0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvp241","article-title":"Interleukin 8 and cardiovascular disease","volume":"84","author":"Apostolakis","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.bcmd.2010.10.010_bb0195","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10875-008-9194-3","article-title":"Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspective","volume":"28","author":"Vogiatzi","year":"2008","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.bcmd.2010.10.010_bb0200","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/01.STR.29.2.462","article-title":"Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA","volume":"29","author":"Kostulas","year":"1998","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.bcmd.2010.10.010_bb0205","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1210\/endo.139.10.6247","article-title":"Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8","volume":"139","author":"Rothe","year":"1998","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bcmd.2010.10.010_bb0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease","volume":"33","author":"Bendre","year":"2003","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bcmd.2010.10.010_bb0215","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines\u2014chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N Engl J. Med."},{"issue":"6676","key":"10.1016\/j.bcmd.2010.10.010_bb0220","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/33340","article-title":"Chemokines and leukocyte traffic","volume":"392","author":"Baggiolini","year":"1998","journal-title":"Nature"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:27:26Z","timestamp":1761049646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979610002512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1079979610002512"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.10.010","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential biomarkers of osteonecrosis in Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}